|
시장보고서
상품코드
2050747
약물전달 기술 시장 : 투여 경로별, 치료 영역별, 최종사용자별, 지역별Drug Delivery Technologies Market, By Route of Administration, By Therapeutic Area, By End User, By Geography |
||||||
약물전달 기술 시장은 2026년에 563억 1,000만 달러로 추계되고 있으며, 2033년까지 1,333억 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 13.1%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 563억 1,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 13.10% | 2033년 시장 규모 예측 : | 1,333억 달러 |
약물전달이란 원하는 치료효과를 안전하게 달성하기 위해 필요에 따라 의약품 화합물을 체내로 안전하게 운반하는 방법, 제형, 기술 및 시스템을 말합니다. 약물 분자의 분해를 방지하고 방출 속도를 조절하여 약효와 안전성을 향상시키기 위해 다양한 약물전달 기술이 개발되어 왔습니다. 면역치료, 유전자치료, 정밀의료 등의 발전은 보다 효과적인 약물전달 방법에 대한 수요를 촉진하고 있습니다. 시장에서는 리포좀, 마이크로스피어, 나노캐리어 등 체내 표적 부위에 약물을 효율적으로 전달할 수 있는 새로운 약물전달 시스템의 혁신이 이루어지고 있습니다. 또한 만성질환의 유병률 증가, 바이오의약품 시장의 성장, 이 분야의 주요 기업의 R&D 투자 증가는 예측 기간 중 시장 성장을 촉진할 것으로 예상되는 주요 요인 중 일부입니다.
시장 역학
세계의 약물전달 기술 시장은 주로 암, 당뇨병, 심혈관 질환과 같은 만성질환의 전 세계 유병률 증가에 의해 주도되고 있습니다. 2023년 9월 세계보건기구(WHO)에 따르면 2021년 전 세계에서 보고된 전체 사망자의 약 60%가 만성질환으로 인한 사망이었다고 합니다. 약물전달시스템은 의약품 치료의 효과와 만성질환 환자의 임상결과 개선에 기여합니다. 또한 바이오의약품 시장의 성장은 고분자 바이오 치료제를 위한 첨단 약물전달 방식에 대한 기회를 창출하고 있습니다. 그러나 새로운 약물전달 시스템의 연구개발 및 제조에 따른 높은 비용이 예측 기간 중 시장 성장을 저해할 수 있습니다. 나노 의료, 주사용 약물전달, 3D 프린팅 분야의 발전은 시장 확대를 위한 유망한 기회를 제공하고 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 매출기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계의 약물전달 기술 시장의 주요 기업 개요을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계의 약물전달 기술 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 약물전달 기술 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 원활하게 할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 약물전달 기술 시장 : 투여 경로별, 2021-2033년
제5장 세계의 약물전달 기술 시장 : 치료 영역별, 2021-2033년
제6장 세계의 약물전달 기술 시장 : 최종사용자별, 2021-2033년
제7장 세계의 약물전달 기술 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
KSA 26.06.10Drug Delivery Technologies Market is estimated to be valued at USD 56.31 Bn in 2026 and is expected to reach USD 133.30 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 56.31 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 13.10% | 2033 Value Projection: | USD 133.30 Bn |
Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Various drug delivery technologies have been developed to improve efficacy and safety of drug molecules by protecting them from degradation and controlling their release rates. Advancements in areas such as immunotherapy, gene therapy, and precision medicine have fueled the demand for more effective drug delivery methods. The market has witnessed innovation of novel drug carrier systems such as liposomes, microspheres, nanocarriers, and other that can efficiently deliver drugs to targeted sites in the body. Furthermore, rising prevalence of chronic diseases, growth of biologics market, and increased R&D investments from key players in this field are some of the key factors expected to drive market growth during the forecast period.
Market Dynamics
Global drug delivery technologies market is primarily driven by the rising global prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. In September 2023, according to the World Health Organization (WHO), chronic diseases accounted for approximately 60% of all reported deaths in the world in 2021. Drug delivery systems help improve the efficacy of pharmaceutical therapies and clinical outcomes of chronic patients. Furthermore, growth of the biologics market has also created opportunities for advanced drug delivery approaches for large molecule biotherapeutics. However, high costs associated with the R&D and manufacturing of novel drug delivery systems may hinder the market growth during the forecast period. Advancements in areas of nanomedicine, injectable drug delivery, and 3D printing offer lucrative opportunities for market expansion.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global drug delivery technologies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Johnson & Johnson Pvt. Ltd., Pfizer Inc., Novartis AG, Merck & Co., Inc., GlaxoSmithKline PLC, Sanofi S.A., Bayer AG, Abbott Laboratories, 3M Company, Antares Pharma, Alkermes PLC, Vectura Group PLC, Generex Biotechnology Corporation, F. Hoffmann-La Roche Ltd., and Medtronic PLC
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global drug delivery technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug delivery technologies market
Market Segmentation
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Oral
- Parenteral
- Intramuscular
- Intravenous
- Intra-Arterial
- Subcutaneous
- Nasal Drug Delivery
- Ocular Drug Delivery
- Topical/Transdermal
- Therapeutic Area Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Cardiology
- Neurology
- Immunology
- Rheumatology
- Diabetes
- Others (Infectious Diseases, etc.)
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Ambulatory Surgical Clinics
- Diagnostic Centers
- Hospitals
- Homecare Settings
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Johnson & Johnson Pvt. Ltd.
- Pfizer Inc.
- Novartis AG
- Merck & Co., Inc.
- GlaxoSmithKline PLC
- Sanofi S.A.
- Bayer AG
- Abbott Laboratories
- 3M Company
- Antares Pharma
- Alkermes PLC
- Vectura Group PLC
- Generex Biotechnology Corporation
- F. Hoffmann-La Roche Ltd.
- Medtronic PLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Drug Delivery Technologies Market, By Route of Administration
- Global Drug Delivery Technologies Market, By Therapeutic Area
- Global Drug Delivery Technologies Market, By End User
- Global Drug Delivery Technologies Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Drug Delivery Technologies Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Intramuscular
- Intravenous
- Intra-Arterial
- Subcutaneous
- Nasal Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ocular Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Topical/Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Drug Delivery Technologies Market, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Rheumatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Infectious Diseases, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Drug Delivery Technologies Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Ambulatory Surgical Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Drug Delivery Technologies Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Route of Administration , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Route of Administration , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Route of Administration , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Johnson & Johnson Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 3M Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Antares Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alkermes PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vectura Group PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Generex Biotechnology Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
